Platelet-derived growth factor release after angioplasty

  • P. Macke Consigny
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 147)

Abstract

The purpose of this chapter is to examine the role of platelet-derived growth factor (PDGF) in the vascular smooth muscle (VSMC) hyperplastic response that occurs in the intima of arteries after balloon angioplasty. This proliferative response results in the reappearance of stenoses in approximately 40% of the patients undergoing coronary balloon angioplasty. To place into perspective the role of PDGF in restenosis, the evidence implicating VSMC proliferation as the cause of restenosis and the approaches that have been used but have failed to resolve the problem are presented. Thereafter, recent cell and molecular biology studies which provide a foundation for the understanding of sources and possible roles of PDGF in restenosis are presented. Finally, PDGF release after angioplasty is described.

Keywords

Catheter Aspirin Cysteine Angiotensin Luminal 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a technique and preliminary report of its application. Circulation 1964; 30: 654–670.Google Scholar
  2. 2.
    Gruentzig AR. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263–266.CrossRefGoogle Scholar
  3. 3.
    Holmes DR, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984; 53: 77C–81C.PubMedCrossRefGoogle Scholar
  4. 4.
    Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H. Hamasaki N, Horiuchi H, Ohishi H. Restenosis after successful coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616–623.PubMedCrossRefGoogle Scholar
  5. 5.
    Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6: 369–375.PubMedCrossRefGoogle Scholar
  6. 6.
    Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol 1990; 15: 419–425.PubMedCrossRefGoogle Scholar
  7. 7.
    Faxon DP, Sanborn TA, Weber VJ, Haudenschild C, Gottsman SB, McGovern WA, Ryan TJ. Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 1984; 4: 189–195.PubMedCrossRefGoogle Scholar
  8. 8.
    Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105–112.PubMedCrossRefGoogle Scholar
  9. 9.
    Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: A necropsy study of 20 patients. J Am Coll Cardiol 1991; 17: 58B–70B.PubMedCrossRefGoogle Scholar
  10. 10.
    Wilentz IR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1987; 75: 636–642.PubMedCrossRefGoogle Scholar
  11. 11.
    Ross R. The pathogenesis of atherosclerosis — an update. N Engl J Med 1986; 314: 488–500.PubMedCrossRefGoogle Scholar
  12. 12.
    Ip JH, Fuster V, Israel D, Badimon L, Badmon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991; 17: 77B–88B.PubMedCrossRefGoogle Scholar
  13. 13.
    Chesebro JH, Webster MWI, Reeder GS, Mock MB, Grill DE, Bailey KR, Steichen S, Fuster V. Coronary angioplasty: Antiplatelet therapy reduces acute complications but not restenosis. 1989; Circ 80: 11–64.Google Scholar
  14. 14.
    Perler BA, Osterman FA, White RI Jr., Williams GM. Percutaneous laser probe femoropopliteal angioplasty: a preliminary experience. J Vasc Surg 1989; 10: 351–357.PubMedGoogle Scholar
  15. 15.
    Buchwald AB, Werner GS, Unterberg C, Voth E, Kreuzer H, Wiegand V. Restenosis after excimer laser angioplasty of coronary stenoses and chronic total occlusions. Am Heart J 1992; 123: 878–885.PubMedCrossRefGoogle Scholar
  16. 16.
    Schatz RA, Goldberg S, Leon M, Bairn D, Hirshfeld J, Cleman M, Ellis S, Topol E. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 1991; 17: 155B–159B.PubMedCrossRefGoogle Scholar
  17. 17.
    Umans VA, Beatt KJ, Rensing BJ, Hermans WR, deFeyter PJ, Serruys PW. Comparative quantitative angiographie analysis of directional coronary atherectomy and balloon coronary angioplasty. Am J Cardiol 1991; 68: 1556–1563.PubMedCrossRefGoogle Scholar
  18. 18.
    Hanke H, Strohschneider T, Oberhoff, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990; 67: 651–659.PubMedCrossRefGoogle Scholar
  19. 19.
    Minar E, Ehringer H, Ahmadi H. Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. Radiology 1989; 170: 767–772.PubMedGoogle Scholar
  20. 20.
    Barrett TB, Gajdusek CM, Schwartz SM, McDougall JK, Bendi EP. Expression of the sis gene by endothelial cells in culture and in vivo. Proc. Natl. Acad Sci. USA 1984; 81: 6772–6774.PubMedCrossRefGoogle Scholar
  21. 21.
    Collins T, Pober JS, Gimbrone MA Jr, Hammacher A, Betsholtz C, Westermark B, Heldin CH. Cultured human endothelial cells express platelet-derived growth factor A chain. Am J Pathol 1987; 126: 7–12.PubMedGoogle Scholar
  22. 22.
    Sitaras NM, Sariban E, Pantazis P, Zetter B, Antoniades HN. Human iliac artery endothelial cells express both genes encoding the chains of platelet-derived growth factor (PDGF) and synthesize PDGF-like mitogen. J Cell Physiol 1987; 132: 376–380.PubMedCrossRefGoogle Scholar
  23. 23.
    Limanni A, Fleming T, Molina R, Hufnagel H, Cunningham RE, Cruess DF, Sharefkin JB. Expression of genes for platelet-derived growth factor in adult human venous endothelium. A possible non-platelet-dependent cause of intimal hyperplasia in vein grafts and perianastomotic areas of vascular prostheses. J Vasc Surg 1988; 7: 10–20.PubMedGoogle Scholar
  24. 24.
    Nilsson J, Sjolund M, Palmberg L, Thyberg J, Heldin CH. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci USA 1985; 82: 4418–4422.PubMedCrossRefGoogle Scholar
  25. 25.
    Sejersen T, Betsholtz C, Sjolund M, Heldin C-H, Westermark B, Thyberg J. Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A-chain but not the gene for the B-chain (c-sis) of platelet derived growth factor (PDGF) and produce a PDGF-like protein. Proc Natl Acad Sci USA 1986; 83: 6844–6848.PubMedCrossRefGoogle Scholar
  26. 26.
    Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth-muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 1986; 83: 7311–7315.PubMedCrossRefGoogle Scholar
  27. 27.
    Sjolund M, Helin U, Sejerson T, Heldin C-H, Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype-and growth state-dependent manner. J Cell Biol 1988; 106: 403–413.PubMedCrossRefGoogle Scholar
  28. 28.
    Valente AJ, Delgado R, Metter JD, Cho C, Sprague EA, Schwartz CJ, Graves DT. Cultured primate aortic smooth muscle cells express both PDGF-A and PDGF-B gene but do not secrete mitogenic activity or dimeric platelet-derived growth factor protein. J Cell Physiol 1988; 136: 479–485.PubMedCrossRefGoogle Scholar
  29. 29.
    Shimokado K, Raines EW, Madtes DK, Barrett TB, Bendi EP, Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985; 43: 277–286.PubMedCrossRefGoogle Scholar
  30. 30.
    Martinet Y, Bitterman PB, Mornex JF, Grotendorst GR, Martin GR, Crystal RG. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature 1986; 319: 158–160.PubMedCrossRefGoogle Scholar
  31. 31.
    Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Maiden LT, Masuko H, Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990; 248: 1009–1012.PubMedCrossRefGoogle Scholar
  32. 32.
    Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986; 46: 155–169.PubMedCrossRefGoogle Scholar
  33. 33.
    Majack RA, Majesky MW, Goodman LV. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-ß. J Cell Biol 1990; 111: 239–247.PubMedCrossRefGoogle Scholar
  34. 34.
    Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243:393–396.PubMedCrossRefGoogle Scholar
  35. 35.
    Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin Invest 1989; 83: 1419–1424.PubMedCrossRefGoogle Scholar
  36. 36.
    Majesky MW, Daemen MJAP, Schwartz SM. αl-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J Biol Chem 1990; 265: 1082–1088.PubMedGoogle Scholar
  37. 37.
    Hart CE, Bowen-Pope DF. Platelet-derived growth factor receptor: current views of the two-subunit model. J Invest Dermatol 1990; 94: 53S–57S.PubMedCrossRefGoogle Scholar
  38. 38.
    Ross R, Bowen-Pope DF, Raines EW. Platelet-derived growth factor and its role in health and disease. Phil Trans R Soc Lond 1990; 327: 155–169.CrossRefGoogle Scholar
  39. 39.
    Terracio L, Ronnstrand L, Tingstrom A, Rubin K, Claesson-Welsh L, Funa K, Heldin C-H. Induction of platelet-derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing. J Cell Biol 1988; 107: 1947–1957.PubMedCrossRefGoogle Scholar
  40. 40.
    Rubin K, Hansson GK, Ronnstrand L, Claesson-Welch L, Fellstrom B, Tingstrum A, Larsson E, Klareskog L, Heldin C-H, Terracio L. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet (June 18) 1988; I: 1353–1356.CrossRefGoogle Scholar
  41. 41.
    Janat MF, Liau G. Transforming growth factor βl is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J Cell Physiol 1992; 150: 232–242.PubMedCrossRefGoogle Scholar
  42. 42.
    Bobik A, Grinpukel S, Little PJ, Grooms A, Jackman G. Angiotensin II and noradrenalin increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA sysnthesis in vascular smooth muscle. Biochem Biophys Res Comm 1990; 166: 580–588.PubMedCrossRefGoogle Scholar
  43. 43.
    Bowen-Pope DF, Hart CE, Weifert RA. Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem 1989; 264: 2502–2508.PubMedGoogle Scholar
  44. 44.
    Barrett TB, Benditt EP. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci USA 1987; 84: 1099–1103.PubMedCrossRefGoogle Scholar
  45. 45.
    Barrett TB, Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal arterial wall. Proc Natl Acad Sci USA 1988; 85: 2810–2814.PubMedCrossRefGoogle Scholar
  46. 46.
    Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988; 82: 1134–1143.PubMedCrossRefGoogle Scholar
  47. 47.
    Libby P, Warner SJC, Salomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Eng J Med 1988; 318: 1493–1498.CrossRefGoogle Scholar
  48. 48.
    Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990; 111: 2149–2158.PubMedCrossRefGoogle Scholar
  49. 49.
    Fingerle J, Au YPT, Clowes AW, Reidy MA. Intimai lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990; 10: 1082–1087.PubMedCrossRefGoogle Scholar
  50. 50.
    Consigny PM, Bilder GE. Expression and release of smooth muscle cell mitogens in the arterial wall after balloon angioplasty. J Vasc Med Biol 1992; In press.Google Scholar
  51. 51.
    Consigny PM, O’Reilly TM, Fernandez AM. Bioassay for smooth muscle cell mitogens released from arteries after angioplasty. Arteriosclerosis and Thrombosis 1991; 1444a.Google Scholar
  52. 52.
    Vlodavsky I, Fridman R, Sullivan R, Sasse J, Klagsbrun M. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor which is secreted. J Cell Physiol 1987; 131: 402–408.PubMedCrossRefGoogle Scholar
  53. 53.
    Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and-BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 1992; 89: 1281–1285.PubMedCrossRefGoogle Scholar
  54. 54.
    Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimai hyperplasia. Circ 1989; 79: 1374–1387.Google Scholar
  55. 55.
    Habenicht AJR, Salbach P, Janssen-Timmen U, Blattner C, Schettler G. Platelet-derived growth factor — a growth factor with an expanding role in health and disease. Klin Wochenschr 1990; 68: 53–59.PubMedCrossRefGoogle Scholar
  56. 56.
    Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: Clues for the development of new preventative therapies. J Am Coll Cardiol 1991; 17: 758–769.PubMedCrossRefGoogle Scholar
  57. 57.
    Cercek B, Sharifi B, Barath P, Bailey L, Forrester JS. Growth factors in pathogenesis of coronary arterial restenosis. Am J Cardiol 1991; 68: 24C–33C.PubMedCrossRefGoogle Scholar
  58. 58.
    Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739–3743.Google Scholar
  59. 59.
    Lindner V, Majack RA, Reidy MA: Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990; 85: 2004–2008.PubMedCrossRefGoogle Scholar
  60. 60.
    Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor-1 mRNA in rat aorta after balloon denudation. Circ Res 1990; 66: 1755–1769.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • P. Macke Consigny

There are no affiliations available

Personalised recommendations